The Medicines and Healthcare products Regulatory Agency grants the first European approval of the Valneva COVID-19 vaccine for people aged between 18 to 50 years.
The Medicines and Healthcare products Regulatory Agency also approvestheuseof the Moderna COVID-19 vaccine for people aged between 6 to 11 years.